HK1028561A1 - Pharmaceutical composition for reducing production of mcp-1 protein - Google Patents

Pharmaceutical composition for reducing production of mcp-1 protein

Info

Publication number
HK1028561A1
HK1028561A1 HK00107851A HK00107851A HK1028561A1 HK 1028561 A1 HK1028561 A1 HK 1028561A1 HK 00107851 A HK00107851 A HK 00107851A HK 00107851 A HK00107851 A HK 00107851A HK 1028561 A1 HK1028561 A1 HK 1028561A1
Authority
HK
Hong Kong
Prior art keywords
mcp
protein
pharmaceutical composition
reducing production
reducing
Prior art date
Application number
HK00107851A
Other languages
English (en)
Inventor
Angelo Guglielmotti
Alberto Mantovani
Original Assignee
Acraf
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Acraf filed Critical Acraf
Publication of HK1028561A1 publication Critical patent/HK1028561A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
HK00107851A 1997-07-28 2000-12-07 Pharmaceutical composition for reducing production of mcp-1 protein HK1028561A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT97MI001789A IT1293795B1 (it) 1997-07-28 1997-07-28 Farmaco attivo nel ridurre la produzione di proteina mcp-1
PCT/EP1998/004924 WO1999004770A2 (fr) 1997-07-28 1998-07-22 Composition pharmaceutique active dans la reduction de production de proteine mcp-1

Publications (1)

Publication Number Publication Date
HK1028561A1 true HK1028561A1 (en) 2001-02-23

Family

ID=11377642

Family Applications (1)

Application Number Title Priority Date Filing Date
HK00107851A HK1028561A1 (en) 1997-07-28 2000-12-07 Pharmaceutical composition for reducing production of mcp-1 protein

Country Status (16)

Country Link
US (1) US6534534B1 (fr)
EP (1) EP1005332B1 (fr)
JP (2) JP4651191B2 (fr)
AR (1) AR016382A1 (fr)
AT (1) ATE251902T1 (fr)
AU (1) AU744492B2 (fr)
CA (1) CA2300289C (fr)
DE (1) DE69819012T2 (fr)
DK (1) DK1005332T3 (fr)
ES (1) ES2207858T3 (fr)
HK (1) HK1028561A1 (fr)
IT (1) IT1293795B1 (fr)
PT (1) PT1005332E (fr)
SI (1) SI1005332T1 (fr)
WO (1) WO1999004770A2 (fr)
ZA (1) ZA986636B (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1
ITMI20062254A1 (it) * 2006-11-24 2008-05-25 Acraf Uso di un acido metossi-alcanoico dell'indazolo per preparare una composizione farmaceutca
US7919518B2 (en) * 2008-03-07 2011-04-05 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.P.A. 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of MCP-1, CX3CR1 and p40
EP2262777B8 (fr) * 2008-03-07 2016-05-04 Aziende Chimiche Riunite Angelini Francesco A.C.R.A.F. S.p.A. Dérivés de 1-benzyl-3-hydroxymethylindazole et utilisation associée dans le traitement des maladies basé sur l'expression de mcp-1 et cx3cr1
BRPI0907974A2 (pt) 2008-03-07 2015-08-04 Acraf Composto, composição farmacêutica, uso de um composto, e, método para tratar ou prevenir doenças
JP5640086B2 (ja) 2009-08-03 2014-12-10 アジェンデ・キミケ・リウニテ・アンジェリニ・フランチェスコ・ア・チ・エレ・ア・エフェ・ソシエタ・ペル・アチオニＡｚｉｅｎｄｅ Ｃｈｉｍｉｃｈｅ Ｒｉｕｎｉｔｅ Ａｎｇｅｌｉｎｉ Ｆｒａｎｃｅｓｃｏ Ａ．Ｃ．Ｒ．Ａ．Ｆ．Ｓｏｃｉｅｔａ Ｐｅｒ Ａｚｉｏｎｉ １−ベンジル−３−ヒドロキシメチル−１ｈ−インダゾール及びその誘導体の製造方法並びに必要なマグネシウム中間体
UA108742C2 (uk) * 2009-09-23 2015-06-10 Фармацевтична композиція для лікування запальних захворювань, опосередкованих mcp-1
EP2539710A4 (fr) 2010-02-25 2016-07-06 Prairie Ventures Llc Système et procédé de manipulation, de stockage et d'analyse d'échantillons anatomopathologiques
US8999292B2 (en) 2012-05-01 2015-04-07 Translatum Medicus Inc. Methods for treating and diagnosing blinding eye diseases
AU2016277126A1 (en) 2015-06-12 2017-12-14 Vettore, LLC MCT4 inhibitors for treating disease
BR112019011825A2 (pt) 2016-12-12 2019-10-22 Vettore Llc composto, enantiômero isolado, composição farmacêutica, método para inibir a atividade do transportador de monocarboxilato mct4, ou um mutante do mesmo, em uma amostra biológica, método para inibir a atividade do transportador de monocarboxilato mct4, ou um mutante do mesmo, em relação ao transportador de monocarboxilato mct1, ou um mutante do mesmo, em um paciente, método para tratar um distúrbio mediado por transportador de monocarboxilato mct4 em um sujeito que necessite do mesmo, uso de um composto e método para obter um efeito em um paciente
CA3144861A1 (fr) 2019-06-25 2020-12-30 Translatum Medicus, Inc. Procedes de fabrication d'acide 2-((1-benzyl-1h-indazol-3-yl)methoxy)-2-methylpropanoique et de ses derives

Family Cites Families (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1230441B (it) * 1989-02-07 1991-10-23 Acraf Eteri della serie dell'indazolo
US5100899A (en) * 1989-06-06 1992-03-31 Roy Calne Methods of inhibiting transplant rejection in mammals using rapamycin and derivatives and prodrugs thereof
IT1253703B (it) * 1991-04-22 1995-08-23 Angelini Francesco Ist Ricerca Uso di acidi metossi alcanoici dell'indazolo per preparare un farmaco attivo nel trattamento di malattie autoimmunitarie
WO1994009128A1 (fr) * 1992-10-22 1994-04-28 Mallinckrodt Medical, Inc. Traitement therapeutique permettant d'inhiber la restenose vasculaire
US5563145A (en) * 1994-12-07 1996-10-08 American Home Products Corporation Rapamycin 42-oximes and hydroxylamines
JPH08333262A (ja) * 1995-04-07 1996-12-17 Chugai Pharmaceut Co Ltd 免疫抑制剤
US6113898A (en) * 1995-06-07 2000-09-05 Idec Pharmaceuticals Corporation Human B7.1-specific primatized antibodies and transfectomas expressing said antibodies
DE19538402A1 (de) * 1995-10-14 1997-04-17 Boehringer Mannheim Gmbh Lipidalkohole als neue immunsuppressive und antivirale Arzneimittel
JPH09165339A (ja) * 1995-10-27 1997-06-24 American Home Prod Corp ラパマイシンを付与したドナー脾細胞を用いる臓器移植の延長
IT1276031B1 (it) 1995-10-31 1997-10-24 Angelini Ricerche Spa Composizione farmaceutica per il trattamento delle malattie autoimmuni
US5780462A (en) * 1995-12-27 1998-07-14 American Home Products Corporation Water soluble rapamycin esters
IT1293795B1 (it) * 1997-07-28 1999-03-10 Angelini Ricerche Spa Farmaco attivo nel ridurre la produzione di proteina mcp-1

Also Published As

Publication number Publication date
DE69819012T2 (de) 2004-08-12
JP5086322B2 (ja) 2012-11-28
ZA986636B (en) 1999-02-04
PT1005332E (pt) 2004-03-31
JP4651191B2 (ja) 2011-03-16
AR016382A1 (es) 2001-07-04
ATE251902T1 (de) 2003-11-15
DK1005332T3 (da) 2004-02-09
JP2001510793A (ja) 2001-08-07
AU744492B2 (en) 2002-02-28
EP1005332B1 (fr) 2003-10-15
WO1999004770A2 (fr) 1999-02-04
AU9160198A (en) 1999-02-16
US6534534B1 (en) 2003-03-18
CA2300289C (fr) 2007-11-20
EP1005332A2 (fr) 2000-06-07
CA2300289A1 (fr) 1999-02-04
JP2010047609A (ja) 2010-03-04
ITMI971789A1 (it) 1999-01-28
IT1293795B1 (it) 1999-03-10
DE69819012D1 (de) 2003-11-20
SI1005332T1 (en) 2004-02-29
ES2207858T3 (es) 2004-06-01
WO1999004770A3 (fr) 1999-04-15

Similar Documents

Publication Publication Date Title
HK1025904A1 (en) Pharmaceutical composition for combination of piperidinoalkanol-decongestant
ZA987800B (en) Pharmaceutical composition of meloxicam
HUP9701554D0 (en) Pharmaceutical composition containing plazma proteins
ZA9810490B (en) 2-Aryl-8-oxodihydropurine derivative process for the preparation thereof pharmaceutical composition containing the same and intermediate therefor
HUP9601698A3 (en) Pharmaceutical composition of adiabetical activity
HUP0101580A3 (en) Pharmaceutical compositions capable of being gelled
IL123986A0 (en) Antithombotic agents process for their preparation and pharmaceutical compositions comprising them
GB9706089D0 (en) Pharmaceutical composition
GB2343117B (en) Benzimidazole pharmaceutical composition and process of preparation
HK1028561A1 (en) Pharmaceutical composition for reducing production of mcp-1 protein
IL134521A (en) Pharmaceutical composition for enhancing the bioavailability of fexofenadine and its derivatives
HUP0202519A2 (en) Production of proteins
IL114673A0 (en) Pharmaceutical compositions containing protein
GB9717444D0 (en) Pharmaceutical composition
GB9717428D0 (en) Pharmaceutical composition
HUP9802716A3 (en) Pharmaceutical composition of analgesic activity
ID24527A (id) Proses pembuatan senyawa-senyawa farmasi
GB2321190B (en) Pharmaceutical composition
IL134050A0 (en) A pharmaceutical composition active in reducing production of mcp-1 protein
ZA981441B (en) Process for preparation of heterocyclic thiol
GB9720963D0 (en) Pharmaceutical compositions and method of production
HU9802107D0 (en) Pharmaceutical composition containing plazma proteins
IL114388A0 (en) Manufacture of pharmaceutical compositions comprising certain arylalkyl-amides
GB9703754D0 (en) Process for preparation of heterocyclic thiol
GB9703753D0 (en) Process for preparation of heterocyclic thiol

Legal Events

Date Code Title Description
PF Patent in force
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20170722